Processa Pharmaceuticals
(NASDAQ) PCSA
Processa Pharmaceuticals Financials at a Glance
Market Cap
$7.16M
Revenue (TTM)
$0.00
Net Income (TTM)
$12.93M
EPS (TTM)
$-34.02
P/E Ratio
-0.09
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$2.39
Volume
145,866
Open
$3.15
Price
$2.39
Volume
145,866
Open
$3.15
Previous Close
$2.33
Daily Range
$2.15 - $3.17
52-Week Range
$1.76 - $19.63
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$2.39
Volume
145,866
Open
$3.15
Previous Close
$2.33
Daily Range
$2.15 - $3.17
52-Week Range
$1.76 - $19.63
PCSA News
PCSA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Processa Pharmaceuticals
PCSA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-271%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-11.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.16M
Shares Outstanding
2.27M
Volume
145.87K
Short Interest
0.00%
Avg. Volume
93.64K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$0.00
EBITDA
$0.00
Operating Cash Flow
$11.39M
Capital Expenditure
$0.00
Free Cash Flow
$11.39M
Cash & ST Invst.
$5.54M
Total Debt
$0.00
Processa Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$7.16M
N/A
Market Cap/Employee
$715.98K
N/A
Employees
10
N/A
Net Income
$3.44M
-1.5%
EBITDA
$3.44M
-0.3%
Quarterly Fundamentals
Net Cash
$5.54M
+395.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-1.66%
N/A
Return on Invested Capital
-2.33%
N/A
Free Cash Flow
$5.63M
-150.5%
Operating Cash Flow
$5.63M
-150.5%